PULSE BIOSCIENCES, INC.

Pulse Biosciences, Inc.

Medical Instruments & Supplies • Healthcare • Miami, FL, United States • PLSE (NCM)

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cycle; and The CellFX Consol, a tunable, software-enabled, and console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

510 906 4600 601 Brickell Key Drive, Miami, FL 33131, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Yahoo Finance • Dec 29
PLSE Stock Today: December 29 – JPM Healthcare Conference Slot Announced - Meyka
Meyka • Dec 30
Pulse Biosciences (PLSE): Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial - Sahm
Sahm • Dec 25
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Business Wire • Dec 19
Pulse Biosciences (PLSE): Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial - simplywall.st
simplywall.st • Dec 26

Other Medical Instruments & Supplies Companies

View All →
INTUITIVE SURGICAL INC logo Intuitive Surgical Inc.
$206.27B market cap
BECTON DICKINSON & CO logo Becton Dickinson & Co.
$55.77B market cap
RESMED INC logo Resmed Inc.
$39.78B market cap
ALCON INC logo Alcon Inc.
$39.62B market cap
Sartorius AG/ADR logo Sartorius AG
$19.99B market cap
WEST PHARMACEUTICAL SERVICES INC logo WEST Pharmaceutical Services Inc.
$19.83B market cap

Frequently Asked Questions

Has PULSE BIOSCIENCES, INC. had layoffs?
No layoff events have been recorded for PULSE BIOSCIENCES, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does PULSE BIOSCIENCES, INC. have?
PULSE BIOSCIENCES, INC. has approximately 75 employees.
What industry is PULSE BIOSCIENCES, INC. in?
PULSE BIOSCIENCES, INC. operates in the Medical Instruments & Supplies industry, within the Healthcare sector.
Is PULSE BIOSCIENCES, INC. a publicly traded company?
Yes, PULSE BIOSCIENCES, INC. is publicly traded under the ticker symbol PLSE on the NCM. The company has a market capitalization of approximately $0.96 billion.
Where is PULSE BIOSCIENCES, INC. headquartered?
PULSE BIOSCIENCES, INC. is headquartered in Miami, FL, United States at 601 Brickell Key Drive, Miami, FL 33131, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.